TreeWAS – Variant ID: rs7092929

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K86.1 Other chronic pancreatitis	0.000	0.826	0.174
K86 Other diseases of pancreas	0.000	0.832	0.168
K86.0 Alcohol-induced chronic pancreatitis	0.000	0.842	0.158
K86.8 Other specified diseases of pancreas	0.000	0.842	0.158
K86.9 Disease of pancreas, unspecified	0.000	0.845	0.155
K86.2 Cyst of pancreas	0.000	0.893	0.107
K86.3 Pseudocyst of pancreas	0.000	0.906	0.094
M47.92 Spondylosis, unspecified (Cervical region)	0.029	0.971	0.000
M47.9 Spondylosis, unspecified	0.024	0.976	0.000
M47.90 Spondylosis, unspecified (Multiple sites in spine)	0.021	0.979	0.000
M47.94 Spondylosis, unspecified (Thoracic region)	0.019	0.981	0.000
M47.95 Spondylosis, unspecified (Thoracolumbar region)	0.019	0.981	0.000
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.018	0.981	0.000
M47.93 Spondylosis, unspecified (Cervicothoracic region)	0.018	0.982	0.000
C15.9 Oesophagus, unspecified	0.000	0.983	0.017
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)	0.017	0.983	0.000
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)	0.016	0.984	0.000
E87.1 Hypo-osmolality and hyponatraemia	0.000	0.984	0.016
L53.9 Erythematous condition, unspecified	0.000	0.984	0.016
T36-T50 Poisoning by drugs, medicaments and biological substances	0.015	0.985	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.015	0.985	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.015	0.985	0.000
H43.1 Vitreous haemorrhage	0.015	0.985	0.000
E87.2 Acidosis	0.000	0.985	0.015
M47 Spondylosis	0.015	0.985	0.000
C15 Malignant neoplasm of oesophagus	0.000	0.985	0.015
M47.99 Spondylosis, unspecified (Site unspecified)	0.014	0.986	0.000
C15.4 Middle third of oesophagus	0.000	0.986	0.014
T40.2 Other opioids	0.014	0.986	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.014	0.986	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.014	0.986	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.014	0.986	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.014	0.986	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.014	0.986	0.000
E87 Other disorders of fluid, electrolyte and acid-base balance	0.000	0.987	0.013
M47.96 Spondylosis, unspecified (Lumbar region)	0.013	0.987	0.000
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.013	0.987	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.013	0.987	0.000
M47.2 Other spondylosis with radiculopathy	0.013	0.987	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.013	0.987	0.000
E87.5 Hyperkalaemia	0.000	0.987	0.013
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.013	0.987	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.013	0.987	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.012	0.988	0.000
C15.3 Upper third of oesophagus	0.000	0.988	0.012
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.012	0.988	0.000
M47.1 Other spondylosis with myelopathy	0.012	0.988	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.012	0.988	0.000
L53 Other erythematous conditions	0.000	0.988	0.012
T43.9 Psychotropic drug, unspecified	0.012	0.988	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.012	0.988	0.000
T36 Poisoning by systemic antibiotics	0.012	0.988	0.000
C15.1 Thoracic part of oesophagus	0.000	0.988	0.012
T43.2 Other and unspecified antidepressants	0.012	0.988	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.012	0.988	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.011	0.989	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.011	0.989	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.011	0.989	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.011	0.989	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.011	0.989	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.011	0.989	0.000
T46.7 Peripheral vasodilators	0.011	0.989	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.011	0.989	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.011	0.989	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.011	0.989	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.011	0.989	0.000
C15.0 Cervical part of oesophagus	0.000	0.989	0.011
M25.46 Effusion of joint (Lower leg)	0.011	0.989	0.000
T40.3 Methadone	0.011	0.989	0.000
M47.0 Anterior spinal and vertebral artery compression syndromes	0.011	0.989	0.000
C15.8 Overlapping lesion of oesophagus	0.000	0.989	0.011
C15.2 Abdominal part of oesophagus	0.000	0.989	0.011
T43.3 Phenothiazine antipsychotics and neuroleptics	0.011	0.989	0.000
T43.6 Psychostimulants with abuse potential	0.011	0.989	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.011	0.989	0.000
L50.9 Urticaria, unspecified	0.000	0.989	0.011
F60 Specific personality disorders	0.010	0.990	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.010	0.990	0.000
T40.8 Lysergide [LSD]	0.010	0.990	0.000
T40.7 Cannabis (derivatives)	0.010	0.990	0.000
T40.0 Opium	0.010	0.990	0.000
T45.0 Antiallergic and antiemetic drugs	0.010	0.990	0.000
M47.20 Other spondylosis with radiculopathy (Multiple sites in spine)	0.010	0.990	0.000
M47.12 Other spondylosis with myelopathy (Cervical region)	0.010	0.990	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.010	0.990	0.000
F60.9 Personality disorder, unspecified	0.010	0.990	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.010	0.990	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.010	0.990	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.010	0.990	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.010	0.990	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.010	0.990	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.010	0.990	0.000
T44.0 Anticholinesterase agents	0.010	0.990	0.000
T40.4 Other synthetic narcotics	0.010	0.990	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.010	0.990	0.000
T38.1 Thyroid hormones and substitutes	0.010	0.990	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.010	0.990	0.000
L50 Urticaria	0.000	0.990	0.010
T40.1 Heroin	0.010	0.990	0.000
F44 Dissociative [conversion] disorders	0.010	0.990	0.000
L50-L54 Urticaria and erythema	0.000	0.990	0.010
T40.5 Cocaine	0.010	0.990	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.010	0.990	0.000
E87.4 Mixed disorder of acid-base balance	0.000	0.990	0.010
C15.5 Lower third of oesophagus	0.000	0.990	0.010
F40-F48 Neurotic, stress-related and somatoform disorders	0.010	0.990	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.010	0.990	0.000
F99 Mental disorder, not otherwise specified	0.010	0.990	0.000
M47.29 Other spondylosis with radiculopathy (Site unspecified)	0.009	0.990	0.000
M47.28 Other spondylosis with radiculopathy (Sacral and sacrococcygeal region)	0.009	0.990	0.000
M47.25 Other spondylosis with radiculopathy (Thoracolumbar region)	0.009	0.990	0.000
M47.24 Other spondylosis with radiculopathy (Thoracic region)	0.009	0.990	0.000
M47.23 Other spondylosis with radiculopathy (Cervicothoracic region)	0.009	0.990	0.000
M47.21 Other spondylosis with radiculopathy (Occipito-atlanto-axial region)	0.009	0.990	0.000
T36.0 Penicillins	0.009	0.990	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.009	0.990	0.000
F43 Reaction to severe stress, and adjustment disorders	0.010	0.990	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.009	0.990	0.000
T37.5 Antiviral drugs	0.009	0.990	0.000
T37.4 Anthelminthics	0.009	0.990	0.000
T37.3 Other antiprotozoal drugs	0.009	0.990	0.000
T37.1 Antimycobacterial drugs	0.009	0.990	0.000
T37.0 Sulphonamides	0.009	0.990	0.000
T38.9 Other and unspecified hormone antagonists	0.009	0.991	0.000
T38.7 Androgens and anabolic congeners	0.009	0.991	0.000
T38.4 Oral contraceptives	0.009	0.991	0.000
T38.2 Antithyroid drugs	0.009	0.991	0.000
T38.5 Other oestrogens and progestogens	0.009	0.991	0.000
L53.8 Other specified erythematous conditions	0.000	0.991	0.009
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.009	0.991	0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.000	0.991	0.009
E87.6 Hypokalaemia	0.000	0.991	0.009
T47.1 Other antacids and anti-gastric-secretion drugs	0.009	0.991	0.000
M47.16 Other spondylosis with myelopathy (Lumbar region)	0.009	0.991	0.000
T38.0 Glucocorticoids and synthetic analogues	0.009	0.991	0.000
F60-F69 Disorders of adult personality and behaviour	0.009	0.991	0.000
T18.1 Foreign body in oesophagus	0.000	0.991	0.009
T45.9 Primarily systemic and haematological agent, unspecified	0.009	0.991	0.000
T45.8 Other primarily systemic and haematological agents	0.009	0.991	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.009	0.991	0.000
T45.6 Fibrinolysis-affecting drugs	0.009	0.991	0.000
T45.4 Iron and its compounds	0.009	0.991	0.000
T45.3 Enzymes, not elsewhere classified	0.009	0.991	0.000
E87.7 Fluid overload	0.000	0.991	0.009
F43.9 Reaction to severe stress, unspecified	0.009	0.991	0.000
M47.19 Other spondylosis with myelopathy (Site unspecified)	0.009	0.991	0.000
M47.18 Other spondylosis with myelopathy (Sacral and sacrococcygeal region)	0.009	0.991	0.000
M47.17 Other spondylosis with myelopathy (Lumbosacral region)	0.009	0.991	0.000
M47.15 Other spondylosis with myelopathy (Thoracolumbar region)	0.009	0.991	0.000
M47.13 Other spondylosis with myelopathy (Cervicothoracic region)	0.009	0.991	0.000
M47.11 Other spondylosis with myelopathy (Occipito-atlanto-axial region)	0.009	0.991	0.000
M47.10 Other spondylosis with myelopathy (Multiple sites in spine)	0.009	0.991	0.000
F60.3 Emotionally unstable personality disorder	0.009	0.991	0.000
T39.0 Salicylates	0.009	0.991	0.000
T45.2 Vitamins, not elsewhere classified	0.009	0.991	0.000
L53.3 Other chronic figurate erythema	0.000	0.991	0.009
L53.2 Erythema marginatum	0.000	0.991	0.009
L53.1 Erythema annulare centrifugum	0.000	0.991	0.009
T40.6 Other and unspecified narcotics	0.009	0.991	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.009	0.991	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.009	0.991	0.000
T41.2 Other and unspecified general anaesthetics	0.009	0.991	0.000
T46.1 Calcium-channel blockers	0.009	0.991	0.000
T47.2 Stimulant laxatives	0.009	0.991	0.000
F99-F99 Unspecified mental disorder	0.009	0.991	0.000
T45.5 Anticoagulants	0.009	0.991	0.000
M47.14 Other spondylosis with myelopathy (Thoracic region)	0.008	0.991	0.000
T36.3 Macrolides	0.008	0.991	0.000
T36.9 Systemic antibiotic, unspecified	0.008	0.991	0.000
T36.7 Antifungal antibiotics, systemically used	0.008	0.991	0.000
T36.6 Rifamycins	0.008	0.991	0.000
T36.5 Aminoglycosides	0.008	0.991	0.000
T36.2 Chloramphenicol group	0.008	0.991	0.000
F44.5 Dissociative convulsions	0.009	0.991	0.000
F44.4 Dissociative motor disorders	0.009	0.991	0.000
F60.5 Anankastic personality disorder	0.009	0.991	0.000
T41.5 Therapeutic gases	0.008	0.991	0.000
T41.4 Anaesthetic, unspecified	0.008	0.991	0.000
T41.3 Local anaesthetics	0.008	0.991	0.000
T41.1 Intravenous anaesthetics	0.008	0.991	0.000
T41.0 Inhaled anaesthetics	0.008	0.991	0.000
M47.27 Other spondylosis with radiculopathy (Lumbosacral region)	0.008	0.991	0.000
F44.9 Dissociative [conversion] disorder, unspecified	0.008	0.991	0.000
T50.1 Loop [high-ceiling] diuretics	0.008	0.991	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.008	0.991	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.008	0.991	0.000
T47.7 Emetics	0.008	0.991	0.000
T47.5 Digestants	0.008	0.991	0.000
T47.3 Saline and osmotic laxatives	0.008	0.991	0.000
F60.8 Other specific personality disorders	0.008	0.992	0.000
E87.3 Alkalosis	0.000	0.992	0.008
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.008	0.992	0.000
F80.1 Expressive language disorder	0.008	0.992	0.000
T36.8 Other systemic antibiotics	0.008	0.992	0.000
T47.0 Histamine H(2)-receptor antagonists	0.008	0.992	0.000
F60.7 Dependent personality disorder	0.008	0.992	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.008	0.992	0.000
Chapter V Mental and behavioural disorders	0.008	0.992	0.000
T47.4 Other laxatives	0.008	0.992	0.000
T49.9 Topical agent, unspecified	0.008	0.992	0.000
T49.8 Other topical agents	0.008	0.992	0.000
T49.7 Dental drugs, topically applied	0.008	0.992	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.008	0.992	0.000
T49.5 Ophthalmological drugs and preparations	0.008	0.992	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.008	0.992	0.000
T49.3 Emollients, demulcents and protectants	0.008	0.992	0.000
T49.2 Local astringents and local detergents	0.008	0.992	0.000
T49.1 Antipruritics	0.008	0.992	0.000
F60.6 Anxious [avoidant] personality disorder	0.008	0.992	0.000
M47.09 Anterior spinal and vertebral artery compression syndromes (Site unspecified)	0.008	0.992	0.000
M47.08 Anterior spinal and vertebral artery compression syndromes (Sacral and sacrococcygeal region)	0.008	0.992	0.000
M47.07 Anterior spinal and vertebral artery compression syndromes (Lumbosacral region)	0.008	0.992	0.000
M47.06 Anterior spinal and vertebral artery compression syndromes (Lumbar region)	0.008	0.992	0.000
M47.05 Anterior spinal and vertebral artery compression syndromes (Thoracolumbar region)	0.008	0.992	0.000
M47.04 Anterior spinal and vertebral artery compression syndromes (Thoracic region)	0.008	0.992	0.000
M47.03 Anterior spinal and vertebral artery compression syndromes (Cervicothoracic region)	0.008	0.992	0.000
M47.02 Anterior spinal and vertebral artery compression syndromes (Cervical region)	0.008	0.992	0.000
M47.01 Anterior spinal and vertebral artery compression syndromes (Occipito-atlanto-axial region)	0.008	0.992	0.000
M47.00 Anterior spinal and vertebral artery compression syndromes (Multiple sites in spine)	0.008	0.992	0.000
F43.1 Posttraumatic stress disorder	0.008	0.992	0.000
F40 Phobic anxiety disorders	0.008	0.992	0.000
L51 Erythema multiforme	0.000	0.992	0.008
F42 Obsessive-compulsive disorder	0.008	0.992	0.000
T47.6 Antidiarrhoeal drugs	0.008	0.992	0.000
L50.8 Other urticaria	0.000	0.992	0.008
O42.9 Premature rupture of membranes, unspecified	0.000	0.992	0.008
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.008	0.992	0.000
T36.4 Tetracyclines	0.008	0.992	0.000
T50.7 Analeptics and opioid receptor antagonists	0.008	0.992	0.000
T50.5 Appetite depressants	0.008	0.992	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.008	0.992	0.000
T50.0 Mineralocorticoids and their antagonists	0.008	0.992	0.000
T50.4 Drugs affecting uric acid metabolism	0.008	0.992	0.000
F60.4 Histrionic personality disorder	0.008	0.992	0.000
F60.1 Schizoid personality disorder	0.008	0.992	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.008	0.992	0.000
F44.0 Dissociative amnesia	0.008	0.992	0.000
F80 Specific developmental disorders of speech and language	0.008	0.992	0.000
L53.0 Toxic erythema	0.000	0.992	0.007
M47.8 Other spondylosis	0.008	0.992	0.000
F60.0 Paranoid personality disorder	0.008	0.992	0.000
T50.8 Diagnostic agents	0.007	0.992	0.000
L52 Erythema nodosum	0.000	0.992	0.007
T50.6 Antidotes and chelating agents, not elsewhere classified	0.007	0.992	0.000
F45 Somatoform disorders	0.007	0.993	0.000
F80-F89 Disorders of psychological development	0.007	0.993	0.000
L50.6 Contact urticaria	0.000	0.993	0.007
L50.5 Cholinergic urticaria	0.000	0.993	0.007
L50.4 Vibratory urticaria	0.000	0.993	0.007
L50.2 Urticaria due to cold and heat	0.000	0.993	0.007
F44.7 Mixed dissociative [conversion] disorders	0.007	0.993	0.000
F44.6 Dissociative anaesthesia and sensory loss	0.007	0.993	0.000
F44.3 Trance and possession disorders	0.007	0.993	0.000
F44.2 Dissociative stupor	0.007	0.993	0.000
F44.1 Dissociative fugue	0.007	0.993	0.000
F60.2 Dissocial personality disorder	0.007	0.993	0.000
L50.1 Idiopathic urticaria	0.000	0.993	0.007
L54 Erythema in diseases classified elsewhere	0.000	0.993	0.007
T39.4 Antirheumatics, not elsewhere classified	0.007	0.993	0.000
T39.2 Pyrazolone derivatives	0.007	0.993	0.000
F69 Unspecified disorder of adult personality and behaviour	0.007	0.993	0.000
L51.1 Bullous erythema multiforme	0.000	0.993	0.007
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.007	0.993	0.000
T48.4 Expectorants	0.007	0.993	0.000
T48.3 Antitussives	0.007	0.993	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.007	0.993	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.007	0.993	0.000
T48.0 Oxytocic drugs	0.007	0.993	0.000
H43 Disorders of vitreous body	0.007	0.993	0.000
F44.8 Other dissociative [conversion] disorders	0.007	0.993	0.000
F43.2 Adjustment disorders	0.007	0.993	0.000
F48 Other neurotic disorders	0.007	0.993	0.000
F43.8 Other reactions to severe stress	0.007	0.993	0.000
L50.3 Dermatographic urticaria	0.000	0.993	0.007
F68 Other disorders of adult personality and behaviour	0.007	0.993	0.000
M25.4 Effusion of joint	0.007	0.993	0.000
T48.5 Anti-common-cold drugs	0.007	0.993	0.000
F61 Mixed and other personality disorders	0.007	0.993	0.000
F40.9 Phobic anxiety disorder, unspecified	0.007	0.993	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.007	0.993	0.000
F65 Disorders of sexual preference	0.007	0.993	0.000
F63 Habit and impulse disorders	0.007	0.993	0.000
F43.0 Acute stress reaction	0.007	0.993	0.000
L50.0 Allergic urticaria	0.000	0.993	0.007
F42.0 Predominantly obsessional thoughts or ruminations	0.007	0.993	0.000
T18 Foreign body in alimentary tract	0.000	0.993	0.007
H43.9 Disorder of vitreous body, unspecified	0.007	0.993	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.007	0.993	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.006	0.994	0.000
M25.45 Effusion of joint (Pelvic region and thigh)	0.006	0.994	0.000
M47.87 Other spondylosis (Lumbosacral region)	0.006	0.994	0.000
F42.1 Predominantly compulsive acts [obsessional rituals]	0.006	0.994	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.006	0.994	0.000
F20.9 Schizophrenia, unspecified	0.006	0.994	0.000
N60.3 Fibrosclerosis of breast	0.000	0.994	0.006
F20 Schizophrenia	0.006	0.994	0.000
F64 Gender identity disorders	0.006	0.994	0.000
M47.86 Other spondylosis (Lumbar region)	0.006	0.994	0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.006	0.994	0.000
T42.3 Barbiturates	0.006	0.994	0.000
T42.1 Iminostilbenes	0.006	0.994	0.000
T85.7 Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts	0.006	0.994	0.000
M47.83 Other spondylosis (Cervicothoracic region)	0.006	0.994	0.000
F45.2 Hypochondriacal disorder	0.006	0.994	0.000
F40.1 Social phobias	0.006	0.994	0.000
F40.0 Agoraphobia	0.006	0.994	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.006	0.994	0.000
F40.2 Specific (isolated) phobias	0.006	0.994	0.000
F70-F79 Mental retardation	0.006	0.994	0.000
L51.8 Other erythema multiforme	0.000	0.994	0.006
L51.2 Toxic epidermal necrolysis [Lyell]	0.000	0.994	0.006
L51.0 Nonbullous erythema multiforme	0.000	0.994	0.006
F42.8 Other obsessive-compulsive disorders	0.006	0.994	0.000
F42.9 Obsessive-compulsive disorder, unspecified	0.006	0.994	0.000
F40.8 Other phobic anxiety disorders	0.006	0.994	0.000
M47.84 Other spondylosis (Thoracic region)	0.006	0.994	0.000
M47.85 Other spondylosis (Thoracolumbar region)	0.006	0.994	0.000
M47.82 Other spondylosis (Cervical region)	0.006	0.994	0.000
F45.3 Somatoform autonomic dysfunction	0.006	0.994	0.000
F42.2 Mixed obsessional thoughts and acts	0.006	0.994	0.000
T39.1 4-Aminophenol derivatives	0.006	0.994	0.000
M25.47 Effusion of joint (Ankle and foot)	0.006	0.994	0.000
F45.9 Somatoform disorder, unspecified	0.006	0.994	0.000
F80.2 Receptive language disorder	0.006	0.994	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.006	0.994	0.000
T42.2 Succinimides and oxazolidinediones	0.006	0.994	0.000
F80.9 Developmental disorder of speech and language, unspecified	0.006	0.994	0.000
F80.8 Other developmental disorders of speech and language	0.006	0.994	0.000
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]	0.006	0.994	0.000
F80.0 Specific speech articulation disorder	0.006	0.994	0.000
M47.81 Other spondylosis (Occipito-atlanto-axial region)	0.006	0.994	0.000
N60.2 Fibroadenosis of breast	0.000	0.994	0.006
O42.1 Premature rupture of membranes, onset of labour after 24 hours	0.000	0.994	0.006
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.006	0.994	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.006	0.994	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.006	0.994	0.000
M25.40 Effusion of joint (Multiple sites)	0.006	0.994	0.000
H43.0 Vitreous prolapse	0.006	0.994	0.000
M25.42 Effusion of joint (Upper arm)	0.006	0.994	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.006	0.994	0.000
F45.1 Undifferentiated somatoform disorder	0.005	0.994	0.000
F89 Unspecified disorder of psychological development	0.005	0.994	0.000
F88 Other disorders of psychological development	0.005	0.994	0.000
F83 Mixed specific developmental disorders	0.005	0.994	0.000
F82 Specific developmental disorder of motor function	0.005	0.994	0.000
L54.8 Erythema in other diseases classified elsewhere	0.000	0.994	0.005
L54.0 Erythema marginatum in acute rheumatic fever	0.000	0.994	0.005
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.005	0.994	0.000
F48.9 Neurotic disorder, unspecified	0.005	0.995	0.000
T42.0 Hydantoin derivatives	0.005	0.995	0.000
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]	0.005	0.995	0.000
F48.8 Other specified neurotic disorders	0.005	0.995	0.000
F48.1 Depersonalisation-derealisation syndrome	0.005	0.995	0.000
C25 Malignant neoplasm of pancreas	0.000	0.995	0.005
F25 Schizoaffective disorders	0.005	0.995	0.000
F45.4 Persistent somatoform pain disorder	0.005	0.995	0.000
M25.41 Effusion of joint (Shoulder region)	0.005	0.995	0.000
H43.3 Other vitreous opacities	0.005	0.995	0.000
M25.49 Effusion of joint (Site unspecified)	0.005	0.995	0.000
M25.48 Effusion of joint (Other)	0.005	0.995	0.000
F68.8 Other specified disorders of adult personality and behaviour	0.005	0.995	0.000
F68.0 Elaboration of physical symptoms for psychological reasons	0.005	0.995	0.000
L51.9 Erythema multiforme, unspecified	0.000	0.995	0.005
F45.0 Somatisation disorder	0.005	0.995	0.000
T18.3 Foreign body in small intestine	0.000	0.995	0.005
F48.0 Neurasthenia	0.005	0.995	0.000
T18.5 Foreign body in anus and rectum	0.000	0.995	0.005
O42 Premature rupture of membranes	0.000	0.995	0.005
F01 Vascular dementia	0.005	0.995	0.000
F63.9 Habit and impulse disorder, unspecified	0.005	0.995	0.000
F63.8 Other habit and impulse disorders	0.005	0.995	0.000
F63.3 Trichotillomania	0.005	0.995	0.000
F63.2 Pathological stealing [kleptomania]	0.005	0.995	0.000
F63.1 Pathological fire-setting [pyromania]	0.005	0.995	0.000
F63.0 Pathological gambling	0.005	0.995	0.000
F65.9 Disorder of sexual preference, unspecified	0.005	0.995	0.000
F65.8 Other disorders of sexual preference	0.005	0.995	0.000
F65.6 Multiple disorders of sexual preference	0.005	0.995	0.000
F65.5 Sadomasochism	0.005	0.995	0.000
F65.4 Paedophilia	0.005	0.995	0.000
F65.3 Voyeurism	0.005	0.995	0.000
F65.2 Exhibitionism	0.005	0.995	0.000
F65.1 Fetishistic transvestism	0.005	0.995	0.000
F65.0 Fetishism	0.005	0.995	0.000
F66.9 Psychosexual development disorder, unspecified	0.005	0.995	0.000
F66.8 Other psychosexual development disorders	0.005	0.995	0.000
F66.2 Sexual relationship disorder	0.005	0.995	0.000
F66.1 Egodystonic sexual orientation	0.005	0.995	0.000
F66.0 Sexual maturation disorder	0.005	0.995	0.000
F21 Schizotypal disorder	0.005	0.995	0.000
F20.2 Catatonic schizophrenia	0.005	0.995	0.000
C25.0 Head of pancreas	0.000	0.995	0.005
F45.8 Other somatoform disorders	0.005	0.995	0.000
T18.8 Foreign body in other and multiple parts of alimentary tract	0.000	0.995	0.005
T18.4 Foreign body in colon	0.000	0.995	0.005
T18.9 Foreign body in alimentary tract, part unspecified	0.000	0.995	0.005
F95 Tic disorders	0.005	0.995	0.000
C25.1 Body of pancreas	0.000	0.995	0.005
F20.8 Other schizophrenia	0.005	0.995	0.000
F28 Other nonorganic psychotic disorders	0.005	0.995	0.000
F24 Induced delusional disorder	0.005	0.995	0.000
T18.0 Foreign body in mouth	0.000	0.995	0.005
K80-K87 Disorders of gallbladder, biliary tract and pancreas	0.000	0.995	0.005
H43.2 Crystalline deposits in vitreous body	0.005	0.995	0.000
F81 Specific developmental disorders of scholastic skills	0.005	0.995	0.000
N60 Benign mammary dysplasia	0.000	0.995	0.005
C25.2 Tail of pancreas	0.000	0.995	0.005
F62.8 Other enduring personality changes	0.005	0.995	0.000
F62.1 Enduring personality change after psychiatric illness	0.005	0.995	0.000
F62.0 Enduring personality change after catastrophic experience	0.005	0.995	0.000
F01.9 Vascular dementia, unspecified	0.005	0.995	0.000
F20.6 Simple schizophrenia	0.005	0.995	0.000
F20.4 Postschizophrenic depression	0.005	0.995	0.000
F20.3 Undifferentiated schizophrenia	0.005	0.995	0.000
F20.1 Hebephrenic schizophrenia	0.005	0.995	0.000
F64.9 Gender identity disorder, unspecified	0.005	0.995	0.000
F64.8 Other gender identity disorders	0.005	0.995	0.000
F64.2 Gender identity disorder of childhood	0.005	0.995	0.000
F64.1 Dual-role transvestism	0.005	0.995	0.000
F94 Disorders of social functioning with onset specific to childhood and adolescence	0.005	0.995	0.000
F93 Emotional disorders with onset specific to childhood	0.005	0.995	0.000
F92 Mixed disorders of conduct and emotions	0.005	0.995	0.000
F91 Conduct disorders	0.005	0.995	0.000
F90 Hyperkinetic disorders	0.005	0.995	0.000
T18.2 Foreign body in stomach	0.000	0.995	0.005
M45-M49 Spondylopathies	0.005	0.995	0.000
F20.5 Residual schizophrenia	0.005	0.995	0.000
F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.005	0.995	0.000
C90.2 Plasmacytoma, extramedullary	0.000	0.995	0.005
F00 Dementia in Alzheimer's disease	0.005	0.995	0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.005	0.995	0.000
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.000	0.995	0.005
T15-T19 Effects of foreign body entering through natural orifice	0.000	0.995	0.005
F02 Dementia in other diseases classified elsewhere	0.005	0.995	0.000
M47.22 Other spondylosis with radiculopathy (Cervical region)	0.004	0.995	0.001
F79 Unspecified mental retardation	0.005	0.995	0.000
F84 Pervasive developmental disorders	0.004	0.995	0.000
F78 Other mental retardation	0.004	0.995	0.000
F73 Profound mental retardation	0.004	0.995	0.000
F72 Severe mental retardation	0.004	0.995	0.000
F71 Moderate mental retardation	0.004	0.995	0.000
C25.9 Pancreas, unspecified	0.000	0.995	0.005
E87.0 Hyperosmolality and hypernatraemia	0.000	0.995	0.004
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.005	0.995	0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.005	0.995	0.000
C25.8 Overlapping lesion of pancreas	0.000	0.995	0.004
K85 Acute pancreatitis	0.000	0.995	0.005
C25.7 Other parts of pancreas	0.000	0.995	0.004
F00.9 Dementia in Alzheimer's disease, unspecified	0.004	0.995	0.000
F70 Mild mental retardation	0.004	0.995	0.000
F20.0 Paranoid schizophrenia	0.004	0.995	0.000
F25.1 Schizoaffective disorder, depressive type	0.004	0.996	0.000
F62.9 Enduring personality change, unspecified	0.004	0.996	0.000
F09 Unspecified organic or symptomatic mental disorder	0.004	0.996	0.000
M25.43 Effusion of joint (Forearm)	0.004	0.996	0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.004	0.996	0.000
T16 Foreign body in ear	0.000	0.996	0.004
N60.1 Diffuse cystic mastopathy	0.000	0.996	0.004
M48 Other spondylopathies	0.004	0.996	0.000
M25.44 Effusion of joint (Hand)	0.004	0.996	0.000
C25.3 Pancreatic duct	0.000	0.996	0.004
F25.9 Schizoaffective disorder, unspecified	0.004	0.996	0.000
F64.0 Transsexualism	0.004	0.996	0.000
K62.6 Ulcer of anus and rectum	0.000	0.996	0.004
D63.8 Anaemia in other chronic diseases classified elsewhere	0.000	0.996	0.004
K85.9 Acute pancreatitis, unspecified	0.000	0.996	0.004
F02.0 Dementia in Pick's disease	0.004	0.996	0.000
F22 Persistent delusional disorders	0.004	0.996	0.000
F29 Unspecified nonorganic psychosis	0.004	0.996	0.000
Z94.8 Other transplanted organ and tissue status	0.000	0.996	0.004
F25.0 Schizoaffective disorder, manic type	0.004	0.996	0.000
F25.8 Other schizoaffective disorders	0.004	0.996	0.000
M47.88 Other spondylosis (Sacral and sacrococcygeal region)	0.004	0.996	0.000
O42.2 Premature rupture of membranes, labour delayed by therapy	0.000	0.996	0.004
F95.2 Combined vocal and multiple motor tic disorder [de la Tourette]	0.004	0.996	0.000
K85.0 Idiopathic acute pancreatitis	0.000	0.996	0.004
T15 Foreign body on external eye	0.000	0.996	0.004
F01.8 Other vascular dementia	0.004	0.996	0.000
F01.3 Mixed cortical and subcortical vascular dementia	0.004	0.996	0.000
F01.2 Subcortical vascular dementia	0.004	0.996	0.000
F01.0 Vascular dementia of acute onset	0.004	0.996	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.004	0.996	0.000
C25.4 Endocrine pancreas	0.000	0.996	0.004
F01.1 Multi-infarct dementia	0.004	0.996	0.000
C92.1 Chronic myeloid leukaemia	0.000	0.996	0.004
N60.9 Benign mammary dysplasia, unspecified	0.000	0.996	0.004
F06.7 Mild cognitive disorder	0.004	0.996	0.000
F25.2 Schizoaffective disorder, mixed type	0.004	0.996	0.000
F95.9 Tic disorder, unspecified	0.004	0.996	0.000
F95.8 Other tic disorders	0.004	0.996	0.000
F95.1 Chronic motor or vocal tic disorder	0.004	0.996	0.000
F95.0 Transient tic disorder	0.004	0.996	0.000
F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction	0.004	0.996	0.000
T19 Foreign body in genito-urinary tract	0.000	0.996	0.004
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.004	0.996	0.000
M48.07 Spinal stenosis (Lumbosacral region)	0.004	0.996	0.000
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere	0.000	0.996	0.004
F81.8 Other developmental disorders of scholastic skills	0.004	0.996	0.000
F81.3 Mixed disorder of scholastic skills	0.004	0.996	0.000
F81.2 Specific disorder of arithmetical skills	0.004	0.996	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations